| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table
|
Mach, François
|
|
|
18 |
5 |
p. e685-e700
|
artikel
|
| 2 |
Association between the proportion of HDL-cholesterol subclasses and the severity of coronary artery stenosis in patients with acute myocardial infarction
|
Geng, Yu
|
|
|
18 |
5 |
p. e710-e719
|
artikel
|
| 3 |
Association between very high HDL-C levels and mortality: A systematic review and meta-analysis
|
Mamede, Isadora
|
|
|
18 |
5 |
p. e701-e709
|
artikel
|
| 4 |
Association of lipid-lowering drugs with gut microbiota: A Mendelian randomization study
|
Shi, Lubo
|
|
|
18 |
5 |
p. e797-e808
|
artikel
|
| 5 |
Attitudes and barriers to lipoprotein(a) testing: A survey of providers at the University of Pennsylvania Health System
|
D'Souza, Jillian
|
|
|
18 |
5 |
p. e873-e876
|
artikel
|
| 6 |
Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association
|
Agarwala, Anandita
|
|
|
18 |
5 |
p. e664-e684
|
artikel
|
| 7 |
Effect of evolocumab on carotid plaque composition in asymptomatic carotid artery stenosis (EVOCAR-1) using magnetic resonance imaging
|
Jones, Ben
|
|
|
18 |
5 |
p. e855-e866
|
artikel
|
| 8 |
Genetic association analyses highlight apolipoprotein B as a determinant of chronic kidney disease in patients with type 2 diabetes
|
Wang, Zhenqian
|
|
|
18 |
5 |
p. e787-e796
|
artikel
|
| 9 |
Higher epicardial adipose tissue volume is associated with higher coronary fatty plaque volume and is regulated by waist circumference but not EPA+DHA supplementation
|
Amangurbanova, Maral
|
|
|
18 |
5 |
p. e773-e786
|
artikel
|
| 10 |
Increased circulating levels of malondialdehyde-modified low-density lipoprotein in patients with coronary microvascular dysfunction
|
Ito, Tsuyoshi
|
|
|
18 |
5 |
p. e756-e763
|
artikel
|
| 11 |
Lipid-lowering therapy with inclisiran in the real-world setting: Initial data from a national health care service
|
Naoum, Ibrahim
|
|
|
18 |
5 |
p. e809-e816
|
artikel
|
| 12 |
Long-term lipoprotein apheresis reduces cardiovascular events in high-risk patients with isolated lipoprotein(a) elevation
|
Schumann, Friederike
|
|
|
18 |
5 |
p. e738-e745
|
artikel
|
| 13 |
NLA Expert Clinical Consensus on apolipoprotein B recommends expanded clinical use and improved patient access
|
Maki, Kevin C.
|
|
|
18 |
5 |
p. e645-e646
|
artikel
|
| 14 |
Race/ethnicity and socioeconomic status affect the assessment of lipoprotein(a) levels in clinical practice
|
Pavlyha, Marianna
|
|
|
18 |
5 |
p. e720-e728
|
artikel
|
| 15 |
Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: Initial experience from the LAI-REACT study
|
Mahajan, Kunal
|
|
|
18 |
5 |
p. e867-e872
|
artikel
|
| 16 |
Real-world experience of long-term efficacy and safety of evinacumab in patients with homozygous familial hypercholesterolemia treated and untreated with lipoprotein apheresis
|
Stefanutti, Claudia
|
|
|
18 |
5 |
p. e817-e824
|
artikel
|
| 17 |
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association
|
Soffer, Daniel E.
|
|
|
18 |
5 |
p. e647-e663
|
artikel
|
| 18 |
Serum mature and furin-cleaved proprotein convertase subtilisin/kexin type 9 levels and their association with cardiovascular events in statin-treated patients with cardiovascular disease
|
Hibi, Kiyoshi
|
|
|
18 |
5 |
p. e844-e854
|
artikel
|
| 19 |
The joint association of lipoprotein(a) and lipoprotein-associated phopholipase A2 with the risk of stroke recurrence
|
Xue, Jing
|
|
|
18 |
5 |
p. e729-e737
|
artikel
|
| 20 |
The role of residual inflammatory risk and LDL cholesterol in patients with in-stent restenosis undergoing percutaneous coronary intervention
|
Zhang, Han
|
|
|
18 |
5 |
p. e746-e755
|
artikel
|
| 21 |
Usefulness of triglyceride-glucose index and homeostatic model assessment for predicting coronary microvascular dysfunction
|
Bulut, Mustafa
|
|
|
18 |
5 |
p. e764-e772
|
artikel
|
| 22 |
Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH study
|
Campbell-Salome, Gemme
|
|
|
18 |
5 |
p. e832-e843
|
artikel
|
| 23 |
Validation of physical examinations of tendon xanthomas and changes in the cutoff values of Achilles tendon thickness on radiography in the clinical criteria of heterozygous familial hypercholesterolemia in Japan
|
Tada, Hayato
|
|
|
18 |
5 |
p. e825-e831
|
artikel
|
Tijdschrift beschrijving